These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 1292974

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Serum osteocalcin in hyperthyroidism].
    Roiter I, Legovini P, Da Rin G, Galliazzo S, Di Virgilio R, Foscolo G, Breda F, Conte N.
    Ann Ital Med Int; 1990; 5(2):95-9. PubMed ID: 2248865
    [Abstract] [Full Text] [Related]

  • 3. Bone remodelling markers and serum cytokines in patients with hyperthyroidism.
    Akalin A, Colak O, Alatas O, Efe B.
    Clin Endocrinol (Oxf); 2002 Jul; 57(1):125-9. PubMed ID: 12100080
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sclerostin and bone metabolism markers in hyperthyroidism before treatment and interrelations between them.
    Sarıtekin İ, Açıkgöz Ş, Bayraktaroğlu T, Kuzu F, Can M, Güven B, Mungan G, Büyükuysal Ç, Sarıkaya S.
    Acta Biochim Pol; 2017 Jul; 64(4):597-602. PubMed ID: 29059259
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.
    Kumeda Y, Inaba M, Tahara H, Kurioka Y, Ishikawa T, Morii H, Nishizawa Y.
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4157-61. PubMed ID: 11095447
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Serum osteocalcin levels in hyperthyroidism before and after antithyroid therapy.
    Barsal G, Taneli F, Atay A, Hekimsoy Z, Erciyas F.
    Tohoku J Exp Med; 2004 Jul; 203(3):183-8. PubMed ID: 15240927
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Bone metabolism during anti-thyroid drug treatment of endogenous subclinical hyperthyroidism.
    Mudde AH, Houben AJ, Nieuwenhuijzen Kruseman AC.
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):421-4. PubMed ID: 7955452
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Bone and calcium metabolism in subclinical autoimmune hyperthyroidism and hypothyroidism.
    Kisakol G, Kaya A, Gonen S, Tunc R.
    Endocr J; 2003 Dec; 50(6):657-61. PubMed ID: 14709834
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
    Langdahl BL, Loft AG, Møller N, Weeke J, Eriksen EF, Mosekilde L, Charles P.
    J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
    [Abstract] [Full Text] [Related]

  • 16. Serum osteoprotegerin and soluble receptor activator of nuclear factor kappaB ligand levels in patients with a history of differentiated thyroid carcinoma: a case-controlled cohort study.
    Giusti M, Cecoli F, Fazzuoli L, De Franchis V, Ceresola E, Ferone D, Mussap M, Minuto F.
    Metabolism; 2007 May; 56(5):699-707. PubMed ID: 17445547
    [Abstract] [Full Text] [Related]

  • 17. Approach to the patient with subclinical hyperthyroidism.
    Cooper DS.
    J Clin Endocrinol Metab; 2007 Jan; 92(1):3-9. PubMed ID: 17209221
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Serum bone Gla protein: a marker of bone turnover in hyperthyroidism.
    Garrel DR, Delmas PD, Malaval L, Tourniaire J.
    J Clin Endocrinol Metab; 1986 May; 62(5):1052-5. PubMed ID: 3485649
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.